Northeast Financial Consultants Inc Novartis Ag Transaction History

Northeast Financial Consultants Inc

  • $2.25 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 30, 2020
SELL
$80.93 - $91.1 $639,347 - $719,690
-7,900 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $13,158 - $14,877
-156 Reduced 1.94%
7,900 $748,000
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $606,777 - $694,024
8,056 New
8,056 $775,000

Others Institutions Holding NVS

# of Institutions
1,438
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email